BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37566023)

  • 1. A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis.
    Alberti-Violetti S; Sapienza MR; Del Corvo M; Melle F; Motta G; Venegoni L; Cerroni L; Cota C; Pileri A; Berti E; Pileri SA
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.
    de Masson A; O'Malley JT; Elco CP; Garcia SS; Divito SJ; Lowry EL; Tawa M; Fisher DC; Devlin PM; Teague JE; Leboeuf NR; Kirsch IR; Robins H; Clark RA; Kupper TS
    Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
    Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG
    J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-stage mycosis fungoides variants: case-based review.
    Cho-Vega JH; Tschen JA; Duvic M; Vega F
    Ann Diagn Pathol; 2010 Oct; 14(5):369-85. PubMed ID: 20850703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ; Moerman-Herzog A; Wong HK
    BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformed Mycosis Fungoides with a Cytotoxic T-Cell Phenotype.
    Hiraiwa S; Hashimoto N; Ueda T; Sugiyama T; Yokoyama K; Matsuyama T; Tajiri T; Nakamura N
    Int J Surg Pathol; 2022 Oct; 30(7):816-822. PubMed ID: 35253522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
    Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
    Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma.
    Gao Y; Liu F; Sun J; Wen Y; Tu P; Kadin ME; Wang Y
    J Invest Dermatol; 2021 Mar; 141(3):607-618.e6. PubMed ID: 32771472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
    J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
    Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
    Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study.
    Lindahl LM; Besenbacher S; Rittig AH; Celis P; Willerslev-Olsen A; Gjerdrum LMR; Krejsgaard T; Johansen C; Litman T; Woetmann A; Odum N; Iversen L
    Blood; 2018 Feb; 131(7):759-770. PubMed ID: 29208599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients.
    Talaat IM; Abdelmaksoud RE; Guimei M; Agamia NF; Nugud A; El-Serafi AT
    PLoS One; 2019; 14(10):e0224305. PubMed ID: 31648231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated review on prognostic factors in mycosis fungoides and new skin lymphoma trials.
    Farabi B; Seminario-Vidal L; Jamgochian M; Akay BN; Atak MF; Rao BK; Karagaiah P; Grabbe S; Goldust M
    J Cosmet Dermatol; 2022 Jul; 21(7):2742-2748. PubMed ID: 34687485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
    Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
    Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
    Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
    Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenomic analysis identifies novel biomarkers for tumor stage mycosis fungoides.
    Dong Z; Zhu X; Li Y; Gan L; Chen H; Zhang W; Sun J
    Medicine (Baltimore); 2018 May; 97(21):e10871. PubMed ID: 29794791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.
    Rindler K; Jonak C; Alkon N; Thaler FM; Kurz H; Shaw LE; Stingl G; Weninger W; Halbritter F; Bauer WM; Farlik M; Brunner PM
    Mol Cancer; 2021 Sep; 20(1):124. PubMed ID: 34583709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.